Curr. Issues Mol. Biol. 2022, 44(1), 288-300; https://doi.org/10.3390/cimb44010021 - 9 Jan 2022
Best Paper Award
Dear Colleagues,
We are pleased to announce the winners of the CIMB 2022 Best Paper Award. All papers published in 2022 in CIMB were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations, and downloads, two winners were selected.
One Review:
Circulating Exosomal miR-1290 for Diagnosis of Epithelial Ovarian Cancer
By Hyeji Jeon, Su Min Seo, Tae Wan Kim, Jaesung Ryu, Hyejeong Kong, Hyeong Jang, Yong Soo Jang, Kwang Seock Kim, Jae Hoon Kim, Seongho Ryu and Seob Jeon
Curr. Issues Mol. Biol. 2022, 44(1), 288-300; doi:10.3390/cimb44010021
One Article:
Lipid Nanoparticles: A Novel Gene Delivery Technique for Clinical Application
By Ryuichi Mashima and Shuji Takada
Curr. Issues Mol. Biol. 2022, 44(10), 5013-5027; doi:10.3390/cimb44100341
Each winner will receive CHF 500 and a chance to publish a paper in CIMB in 2024.
Please join us in congratulating the winners of the CIMB 2022 Best Paper Award. We would also like to take this opportunity to thank all of our authors for their continued support of CIMB.
Kind regards,
CIMB Editorial Office
CIMB 2022 Best Paper Award
Eligibility and Requirements
– All papers published in CIMB will be eligible (Both regular and Special Issue submissions).
Past Winners
Year:
Winner
Circulating Exosomal miR-1290 for Diagnosis of Epithelial Ovarian Cancer
Lipid Nanoparticles: A Novel Gene Delivery Technique for Clinical Application
Curr. Issues Mol. Biol. 2022, 44(10), 5013-5027; https://doi.org/10.3390/cimb44100341 - 19 Oct 2022
